Torrent Pharma

Torrent Pharma acquires 4 Brands from Dr.Reddy’s laboratories

New Delhi, May 29, 2022: Ahmedabad based Torrent Pharmaceuticals today announced that it has entered into an agreement with Dr.…

2 years ago

Torrent Pharma enters into licensing agreement with Medicine Patent Pool to manufacture and commercialise generic version of Pfizer Oral COVID-19 Treatment

New Delhi, March 20, 2022: Torrent Pharmaceuticals Limited (herein after referred to as “TPL”) has announced that it has signed…

3 years ago

Torrent Pharma announces Q3 FY22 results

Continued pressure on US business offsets robust India performance New Delhi, January 29,2022: Revenues & profitability: Revenue at 2,108 crores…

3 years ago

Torrent Pharma recalls around 2.30 lakh bottles of high BP treatment tablets from US

New Delhi, March 03, 2019: Torrent PharmaceuticalsNSE -0.90 % is recalling 2,29,896 bottles of tablets used for treatment of high blood…

6 years ago

Global Onychomycosis Drug Market 2018 Opportunities: J&J, Torrent Pharma, Chengdu Brilliant and Yangtze River

New Delhi, June 11, 2018:  Global Onychomycosis Drug research report offers an expert and thorough analysis of the present condition alongside…

6 years ago

Torrent Pharma up 3%; issues commercial paper of Rs 300 cr, board meeting on May 30

A meeting of the board of directors will be held on May 30, 2018, to consider and approve the audited…

6 years ago

Brazil’s EMS and Also India’s Torrent Pharma Cried for Sanofi’s generic Medications: Resources

London, February 08, 2018: Brazilian drugs company EMS and Indian rival Torrent Pharma have emerged since the sole sector bidders…

7 years ago